DCN and neoplasm: Indeed, reduced expression of decorin is associated with poor prognosis and may promote tumorigenesis and invasion (105), while its overexpression is associated with better prognosis and leads to tumor growth and metastasis inhibitions (through ERbB2 inhibition) (106–108).